Obesity and diabetes

Module 1: Obesity and the pathogenesis and outcomes of type 2 diabetes

Please log in to access the chapters in this module.
CME Credits: 1
Module duration: 1 hour
Launch date: Autumn 2021 (version 1)
Updated: Summer 2022 (version 2)
Expiry date: March 2027
Audience: Diabetes and Metabolism Specialists (Subspeciality), Endocrinologists (Subspeciality), General Physicians (Subspeciality)

Hello, my name is Naveed Sattar. I’m Professor of Metabolic Medicine at the University of Glasgow. I’m here today to talk about obesity and its links to type 2 diabetes pathogenesis and its cardiovascular outcomes. So the outline I thought I would follow is really a talk in two parts. The first part is to explain how diabetes, through ectopic fat and excess fuel, links to cardiovascular and cardiorenal risks – and also how it actually links to the development of hyperglycaemia per se. Then, in part two, to explain why that excess weight is actually more pronounced in younger people with type 2, which partly explains their higher life years lost due to diabetes. But also, on the opposite side of the equation, how non-white ethnicity – so really, everybody who’s not white – actually has to put on less weight to develop diabetes. That will then explain why people of certain ethnicities develop diabetes sooner but, on the other hand, it may also explain why those ethnicities lose fewer life years due to diabetes.

This module looks at the factors that link obesity to type 2 diabetes and associated cardiovascular and cardiorenal risks, including examination of the ways in which age, gender and ethnicity influence the trajectory of weight gain-related health outcomes.

Learning Outcomes

By the end of this module, you will be able to:

Outline the relationship between obesity, type 2 diabetes and hyperglycaemia and the consequences of type 2 diabetes and obesity

Explain how age, gender and ethnicity affect the linkages between weight gain and type 2 diabetes and its complications

Identify the benefits of preventing type 2 diabetes and reducing cardiovascular risk, including the effectiveness of intervention


This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.


Contributors

Professor
Naveed Sattar
Author, Assessment Setter
Professor
Dan Cuthbertson
Expert Reviewer
Assessment Setter
Assessment Setter